Cite
HARVARD Citation
McLoughlin, H. et al. (2018). Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. Annals of neurology. 84 (1), pp. 64-77. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McLoughlin, H. et al. (2018). Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice. Annals of neurology. 84 (1), pp. 64-77. [Online].